Attenuation of oxidative and nitrosative stress in cortical area associates with antidepressant-like effects of tropisetron in male mice following social isolation stress. by Haj-Mirzaian, Arya. et al.
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a  b  s  t  r  a  c  t
Tropisetron,  a 5-HT3  receptor  antagonist  widely  used  as  an  antiemetic,  has  been  reported  to have  posi-
tive  effects  on mood  disorders.  Adolescence  is  a critical  period  during  the  development  of brain,  where
exposure  to chronic  stress  during  this  time  is highly  associated  with  the  development  of depression.
In  this  study,  we showed  that  4 weeks  of  juvenile  social  isolation  stress  (SIS)  provoked  depressive-like
behaviors  in male  mice,  which  was  associated  with  disruption  of  mitochondrial  function  and nitric  oxide
overproduction  in  the  cortical  areas.  In this  study,  tropisetron  (5 mg/kg)  reversed  the  negative  behavioral
effects  of  SIS  in  male mice.  We  found  that  the  effects  of  tropisetron  were  mediated  through  mitigating
the  negative  activity  of inducible  nitric  oxide  synthase  (iNOS)  on  mitochondrial  activity.  Administration
of  aminoguanidine  (speciﬁc  iNOS  inhibitor,  20  mg/kg)  augmented  the protective  effects  of  tropisetronitric oxide
itochondrial dysfunction
(1  mg/kg)  on  SIS.  Furthermore,  l-arginine  (nitric  oxide  precursor,  100  mg/kg)  abolished  the  positive
effects  of tropisetron.  These  results  have  increased  our  knowledge  on  the  pivotal  role  of  mitochondrial
function  in the  pathophysiology  of  depression,  and  highlighted  the  role  of  5-HT3 receptors  in psychosocial
stress  response  during  adolescence.  Finally,  we observed  that  tropisetron  alleviated  the  mitochondrial
dysfunction  through  decreased  nitrergic  system  activity  in  the  cerebral  cortex.
© 2016  Elsevier  Inc.  All  rights  reserved.. IntroductionChronic psychological stress, mainly during the developmental
iming of the brain, is considered to be a potent risk factor in the
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361-9230/© 2016 Elsevier Inc. All rights reserved.development of psychiatric disorders, including depression (Lupien
et al., 2009). Major depressive disorder (MDD) is a debilitating
mental disorder with high prevalence, morbidity, and costly socioe-
conomic burden (Mrazek et al., 2014). Emerging lines of research
indicate that experiencing social adversity during adolescence is
linked to the onset of mood-related psychopathologies (Andersen
and Teicher, 2008). Evidence from animal studies has demonstrated
that post-weaning social isolation stress (SIS) induces a wide vari-
ety of behavioral abnormalities including depressive-like behaviors
(Berry et al., 2012; Fone and Porkess, 2008). Adolescence is a crit-
ical time during brain development with speciﬁc importance in
the development of cortical areas (Andersen and Teicher, 2008).
A. Haj-Mirzaian et al. / Brain Research Bulletin 124 (2016) 150–163 151
Fig. 1. Effect of housing condition on behaviors related to depression. Effect of different housing conditions, social condition (SC) and isolated condition (IC), on the immobility
time  in the FST (a), grooming activity time in the splash test (b), total distance moved in the OFT (c), and number of rearings in the OFT (d). Values are expressed as the
mean  ± S.E.M. of 8 animals and were analyzed using t-test. **P < 0.01 and ***P < 0.001 compared with the SC control group.
Fig. 2. Effect of tropisetron treatment on behaviors related to depression in different housing conditions. Effects of tropisetron (1, 3, and 5 mg/kg) on the immobility time
in  the FST (a), grooming activity time in the splash test (b), total distance moved in the OFT (c), and number of rearings in the OFT (d) in different housing conditions, social
condition (SC) and isolated condition (IC). Values are expressed as the mean ± S.E.M. of 8 animals and were analyzed using one-way ANOVA followed by Tukey’s post hoc
test.  *P < 0.05, **P < 0.01, and ***P < 0.001 compared with the SC control group. #P < 0.05, ##P < 0.01, and ###P < 0.001 compared with the IC saline-treated group (S group).
C:  control group; S: saline group.
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Fig. 3. Effect of NO agents on behaviors related to depression in different housing conditions. Effects of NO agents including L-NAME (LNM) 5 and 10 mg/kg, Aminoguanidine
(AG)  20 and 50 mg/kg, and l-arginine (l-arg) 50 and 100 mg/kg on the immobility time in the FST (a), grooming activity time in the splash test (b), total distance moved in
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urthermore, the developing brain requires high levels of energy,
hich is provided by mitochondria (more than 90% of brain energy)
Ikonomidou and Kaindl, 2011). Recent studies suggest that mito-
hondrial dysfunction plays key roles in pathophysiology of MDD
Morava and Kozicz, 2013). In this regard, independent groups
ave demonstrated that chronic stress increases oxidative and
itrosative stress (O&NS) and excitatory neurotransmission as well
s mitochondrial dysfunction in the regions of the brain related to
athophysiology of MDD  (Maes et al., 2011). Under chronic stress,
n increase in energy demand results in the overproduction of
itochondrial-induced reactive oxygen species (ROS) and nitric
xide (NO) which triggers a cascade of molecular alterations lead-
ng to oxidative damage to brain structures such as cortical areas
Brown and Bal-Price, 2003; Chen et al., 2015). Clinical and preclin-
cal evidence suggest that therapeutic properties of antidepressant
rugs are partly associated with their ability to modulate the O&NS
nd mitochondrial dysfunction (Maes et al., 2012).
Despite extensive research on new therapeutic drug treatments
or depression, the efﬁcacy of currently prescribed antidepressants
s only 40–50 percent (Trivedi et al., 2014). A growing body of evi-
ence indicates that 5-hydroxytryptamine receptors type 3 (5-HT3)
ntagonists (such as tropisetron) have antidepressant-like effects
n animal models of depression (Carr and Lucki, 2011; Rajkumar and
ahesh, 2010). In this context, results in our laboratory and others
ave revealed that tropisetron, in addition to its known anti-emetic
ffect, has a protective effect against O&NS challenge, excitotoxicity
nd inﬂammatory responses under pathophysiological conditions
Rahimian et al., 2011; Rahimian et al., 2013; Swartz et al., 2013).
It has been well documented that excessive NO production
egatively affects mitochondrial function and contributes to the
athogenesis of a vast majority of brain disorders such as depres-ondition (SC) and isolated condition (IC). Values are expressed as the mean ± S.E.M.
 *P < 0.05, **P < 0.01, and ***P  < 0.001 compared with the SC control group. #P < 0.05,
sion and anxiety (Amiri et al., 2015a; Chen et al., 2015). Results
of our laboratory and others have shown that chronic stress (such
as SIS) is able to induce behavioral abnormalities in mice through
overproduction of NO (mainly by iNOS) and cortical areas are more
susceptible to detrimental impact of stress (Amiri et al., 2015b;
Filipovic´ et al., 2011; Olivenza et al., 2000; Zlatkovic´ et al., 2014).
In addition, recent clinical research revealed that cortical areas
(such as frontal, parietal and cingulate regions) are more vulner-
able to the effects of MDD  during early neurodevelopmental stages
of brain (Peng et al., 2015). In a recent study, we focused on the
role of mitochondria and anti-oxidant system and their interac-
tions with nitrergic system in the cortex. Considering that 5-HT3
receptors have a critical role in the development of brain and
nearly 30% of cortical interneurons are 5-HT3 positive cells that
regulate inhibitory and excitatory processes, we focused on the cor-
tex and investigated whether tropisetron is able to attenuate the
depressive-like behaviors in male mice following four weeks of SIS
during adolescence. We used a post-weaning SIS paradigm in this
study because this paradigm evokes a variety of neurobehavioral
changes in the animals similar to behavioral difﬁculties observed in
individuals with psychiatric disorders such as depression (Nestler
and Hyman, 2010; Powell et al., 2012).
2. Materials and methods
2.1. Animals and conditionsMale NMRI mice weighing 10–14 g on postnatal day (PND)
21–25 were used in our study (Pasteur Institute, Tehran, Iran).
PND 21–25 animals were randomly housed in either of the fol-
lowing two opposite conditions for 4 weeks: (1) social condition
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Fig. 4. Effects of tropisetron and NO agents co-administrations on immobility time in the FST. (a and b) Effect of treatment with L-NAME (5 mg/kg) on tropisetron-treated
animals (1 mg/kg) in SC and IC animals. (c and d) Effect of treatment with AG (20 mg/kg) on sub-effective tropisetron-treated animals (1 mg/kg) in SC and IC animals. (e and
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alues  are expressed as the mean ± S.E.M. of 6–8 animals and were analyses using t
ehicle-treated IC group. ##P < 0.01 compared with tropisetron (5 mg/kg)-treated I
SC), or (2) isolated condition (IC). The SC mice were housed (6 per
age) in Plexiglas boxes (25 cm × 25 cm × 15 cm)  and IC mice were
oused individually in Plexiglas boxes (24 cm × 17 cm × 12 cm) in
ormal day-room light (12-h regular light/dark cycle) and temper-
ture (22 ± 1 ◦C). Wood shavings were used as bedding for animals,
nd mice were allowed unlimited access to food and water. Cages
f isolated animals were cleaned weekly by the same experimenter
o minimize handling and social contact. All experiments were con-
ucted during the period between 10:00 a.m. and 2:00 p.m. Each
xperimental group consisted of 6–8 mice in behavioral tests and
–8 mice in molecular evaluations. All procedures in our study wereective dose) in SC and IC animals. The duration on immobility evaluated using FST.
ay ANOVA followed by Tukey’s post hoc test. *P < 0.05 and **P < 0.01 compared with
p. Vehicle refers to saline administration in each parts of ﬁgure.
carried out in accordance with the National Institute of Health (NIH)
Guide for the Care and Use of Laboratory Animals (HHS publication
85-23, 1985) and legislation for the protection of animals used for
scientiﬁc purposes (Directive 2010/63/EU), and we  also adhered
to institutional guidelines for animal care and use (Department of
Pharmacology, School of Medicine, TUMS).2.2. Drugs and treatments
The following drugs were used in this study: (1) tropisetron,
5-HT3 receptor antagonist. (2) NG-l-arginine methyl ester (L-
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Fig. 5. Effects of tropisetron and NO agents co-administrations on grooming activity time in the splash test. (a and b) Effect of treatment with L-NAME (5 mg/kg) on
tropisetron-treated animals (1 mg/kg) in SC and IC animals. (c and d) Effect of treatment with AG (20 mg/kg) on sub-effective tropisetron-treated animals (1 mg/kg) in SC
and  IC animals. (e and f) Effect of treatment with l-arg (100 mg/kg) on effective tropisetron-treated animals (5 mg/kg) in SC and IC animals. The duration grooming activity
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**P  < 0.001 compared with vehicle-treated IC group. #P < 0.05 compared with tropi
gure.
AME), a non-selective nitric oxide synthase or NOS inhibitor. (3)
minoguanidine (AG), a selective inducible NOS or iNOS inhibitor.
4) l-Arginine, a NO precursor. All drugs were purchased from
igma, St. Louis, MO,  USA. All drugs were dissolved in physiolog-
cal saline prior to use for each experiment. All injections were
hrough intraperitoneal (i.p.) route and with a volume of 5 ml/kg
ody weight. The doses of drugs were chosen according to pre-
ious studies, as well as our pilot studies (described below). We
reated mice with l-arginine (30 min), AG and L-NAME (45 min) and
ropisetron (60 min) prior to behavioral or molecular experiments.re analyses using two-way ANOVA followed by Tukey’s post hoc test. *P < 0.05 and
 (5 mg/kg)-treated IC group. Vehicle refers to saline administration in each parts of
2.3. Forced swimming test (FST)
The FST was  directed using the described methods by Haj-
Mirzaian et al. (2015a,b), Porsolt et al. (1977a,b). In this behavioral
test, extended immobility time presents the despair behav-
ior reﬂecting the depressive-like symptoms (Cryan and Holmes,
2005). Mice were separately placed in an open cylinder-shaped
ﬂask (diameter 10 cm,  height 25 cm), containing 19 cm water at
23 ± 1 ◦C. Mice were permitted to swim for 6 min  and the period
of immobility was recorded throughout the last 4 min of the test.
Each mouse was judged to be immobile when it ceased struggling
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Fig. 6. Effects of tropisetron and NO agents co-administrations on total distance moved in the OFT. (a and b) Effect of L-NAME (5 mg/kg) administration on tropisetron-treated
animals (1 mg/kg) in SC and IC animals. (c and d) Effect of AG (20 mg/kg) administration on sub-effective tropisetron-treated animals (1 mg/kg) in SC and IC animals. (e and f)
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xpressed as the mean ± S.E.M. of 6–8 animals and were analyses using two-way A
arts  of ﬁgure.
nd stayed ﬂoating motionless in the water, making only those
ovements necessary to keep its head above water.
.4. Splash test
Splash test was used to assess motivational and self-care dif-
culties, often indicated depression disorder in animals (Ducottet
t al., 2003; Haj-Mirzaian et al., 2015a; Marrocco et al., 2014; Petit
t al., 2014). Lack of motivation and self-care behaviors, as the
ymptoms of depression, is determined by a reduction in groom-
ng activity time. In this behavioral test, grooming activity of mice
ncluding nose/face grooming, head washing and body groom-
ng, which considered as an indirect measure of pleasant solutionkg) in SC and IC animals. The total distance moved evaluated using OFT. Values are
 followed by Tukey’s post hoc test. Vehicle refers to saline administration in each
intake, was  recorded. A 10% sucrose solution was spurted on the
dorsal coat of animals in their home cage mice and was ﬁlmed for
5 min. The total grooming activity time was  recorded during 5 min
after the sucrose vaporization.
2.5. Open-ﬁeld test (OFT)
Open-ﬁeld test was  used to elucidate the effects of SIS and treat-
ments on motor function, exploratory behavior, and to rule out
possible alterations in locomotion that might affect FST. In this
study, we used OFT in order to evaluate the behavioral changes
in mice resulting from stress. The device consisted of a wooden
box measuring 50 cm × 50 cm × 30 cm.  The surface of the box was
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Fig. 7. Effects of tropisetron and NO agents co-administrations on number of rearings in the OFT. (a and b) Effect of L-NAME (5 mg/kg) treatment on tropisetron-treated
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lnimals (1 mg/kg) in SC and IC animals. (c and d) Effect of AG (20 mg/kg) treatment o
f  L-arg (100 mg/kg) treatment on effective tropisetron-treated animals (5 mg/kg) in
he  mean ± S.E.M. of 6–8 animals and were analyses using two-way ANOVA followe
eparated into 16 equal squares. Each mouse was placed gently on
he center square (30 cm × 30 cm)  and its behaviors were recorded
y a camera for 5 min  and analyzed by Ethovision software ver-
ion 8 (Noldus, Netherlands) (Kordjazy et al., 2015; Kulesskaya
nd Voikar, 2014). The total distance moved (horizontal activity)
nd the number of rearings (vertical activity) were evaluated. The
pparatus was cleaned with 70% ethanol after testing each mouse..6. Nitrite assay
To determine the NO levels in cortex tissue, we measured nitrite
evels as the result of the NO end product (Ding et al., 2010). Theeffective tropisetron-treated animals (1 mg/kg) in SC and IC animals. (e and f) Effect
d IC animals. The number of rearings evaluated using OFT. Values are expressed as
ukey’s post hoc test. Vehicle refers to saline administration in each parts of ﬁgure.
animals were decapitated under anesthesia using halothane, and
then the whole brain cortex was  dissected on ice-cold surface
and immediately immersed in liquid nitrogen. Tissue homogenates
were prepared, and the nitrite levels were measured by a colori-
metric assay based on the Griess reaction. Firstly, 100 l of samples
were mixed with 100 l Griess reagent. After a 10-min incubation
at room temperature, the absorbance was measured at 540 nm in
an automated plate reader. The concentration of nitrite was  deter-
mined by reference to a standard curve of sodium nitrite (Sigma,
USA) and normalized to the weight of each sample.
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Fig. 8. Effects of different housing conditions and treatments on ROS formation in the cortex. The ROS in each sample was read with 485 nm excitation and 520 nm emission
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.7. Determination of ATP and glutathione (GSH) levels
At the end of the behavioral tests, the mice were anesthetized
nd whole brain cortex tissue was dissected and washed in cold
tandard saline at 4 ◦C. In order to measure the ATP level, sample tis-
ue extract of each mouse was sonicated in 250 l of trichloroacetic
cid (TCA 6%) and then centrifuged at 12,000g for 10 min  at 4 ◦C. The
upernatant was collected and neutralized with potassium hydrox-
de (KOH = 4 M)  and samples were immediately stored at −80 ◦C for
iochemical assessment (ATP and GSH). ATP levels were measured
sing a luciferase enzyme activity assay as described in our previous
ork (Eskandari et al., 2012). Bioluminescence intensity was  mea-
ured using a Sirius tube luminometer (Berthold Detection System,
ermany). Glutathione levels were determined by spectrophotom-
try method using 5,5′dithio-bis-2-nitrobenzoic acid (DTNB) as
he indicator. To do this, 0.1 ml  of supernatant was added into
.1 mol  L−1 of phosphate buffer and 0.04% DTNB in a total volume
f 3.0 ml  (pH 7.4). Colorimetric measurement at 412 nm was per-
ormed using a spectrophotometer (UV-1601 PC, Shimadzu, Japan).
SH content was expressed as g/mg protein (Jayakumar et al.,
014).
.8. Measurement of reactive oxygen spices (ROS) formation
ﬂow cytometry analysis)
In cellular toxicology, mitochondria can be considered as one of
he major sources for generation of ROS. Therefore, it decided to
etermine the mitochondrial ROS formation in the tissue extract
f each mouse. We  isolated mitochondria by ultracentrifuga-
ion, following the method according to Hosseini et al. (2014).
he cortex were removed and minced with small scissors in a
old mannitol solution (containing 0.225 M d-mannitol, 75 mM
ucrose and 0.2 mM EDTA), then gently homogenized and cen-
rifuged at 10,000g at 4 ◦C. The mitochondrial protein content
as determined using the Bradford assay method with bovinetograms are shifting the ROS peak to the right ward not just increased AUC. (A)
G-20 mg/kg; (G) IC + l-arg-100 mg/kg; (H) IC + l-arg-100 mg/kg + Trop-5 mg/kg; (I)
serum albumin as the standard (Bradford, 1976) and the mito-
chondrial protein concentration was adjusted to 100 g/ml protein.
ROS formation experiments were performed by incubation of 2′,7′-
dichloroﬂuorescein diacetate (DCFH-DA) (ﬁnal concentration of
10 M)  in respiratory buffer solution containing 130 mM KCl, 5 mM
MgCl2, 20 mM NaH2PO4, 1.7 mM ADP, 0.1 mM -NADPH, 0.1 mM
FeCL3 (pH = 7.4) according to the method described by Mashayekhi
et al. (2015). All samples were incubated at 30 ◦C and protected
from light for 15 min. Mitochondrial ﬂuorescence and light scat-
tering were analyzed for at least 15000 counts by ﬂowcytometry
using the Flomax software (Partec, Deutschland). A ﬂowcytometer
(Partec, Deutschland) equipped with a 488-nm argon ion laser was
used and ﬂuorescence signals were obtained using a 530-nm band
pass ﬁlter (FL-1 channel) (Gao et al., 2009; Eskandari et al., 2015).
2.9. Experimental design and treatments
To determine the effect of social isolation on animal behav-
iors after exposure to different housing conditions (SC or IC),
animals at age PND 50–55 (early adulthood) were subjected to
the experiments. In the ﬁrst part of the study, the effects of
SIS on depressive-like behaviors and locomotor activity were
investigated. The effect of SIS on depressive-like behaviors was
determined using FST and splash test, and the locomotor activity
of mice was evaluated by OFT. In order to minimize the number
of animals used in this study, the same mice tested using OFT was
immediately evaluated using FST. Different sets of mice were eval-
uated using splash test.
The second part of the study was  aimed to determine the possi-
ble effect of tropisetron as well as NO agents on the depressive-like
behaviors evoked by adolescent SIS. In this regard, different sets
of SC and IC mice were treated with different doses of following
drugs: tropisetron (1, 3, and 5 mg/kg), L-NAME (5, 10 mg/kg), AG
(20, 50 mg/kg), and l-arg (50, 100 mg/kg). After administration of
drugs, SC animals and IC animals were subjected to the aforemen-
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ioned behavioral tasks. Doses and time of administration of each
rug were chosen according to the pilot treatments and pervious
ublished studies (Amiri et al., 2015b; Amiri et al., 2014; Barzegar-
allah et al., 2014; Bravo and Maswood, 2006; Rahimian et al.,
011). To exclude the possible impact of saline administration on
nimal behaviors, a number of IC and SC were injected with 5 ml/kg
hysiological saline.
The next part of the study was carried out to determine the
ossible role of the nitrergic system in mediating antidepressant-
ike effects of tropisetron. Therefore, sub-effective doses of L-NAME
5 mg/kg) and AG (20 mg/kg) co-administered with sub-effective
ose of tropisetron (1 mg/kg) to both SC and IC mice. Also, we co-
dministered sub-effective dose of l-Arg (100 mg/kg) with effective
ose of tropisetron (5 mg/kg).
Next, we investigated the effects of different housing conditions
nd drug treatments on the cortical levels of nitrite, GSH, ATP, and
OS production in the different sets of SC and IC animals. Differ-
nt groups of SC and IC mice were used for molecular evaluations
these animals had not been tested by behavioral tasks), in order
o avoid the possible effects of behavioral experiments and manip-
lations on these parameters. Further, samples were not pooled
ogether, and each sample of each animal was evaluated separately
or assessing GSH, ATP, NO levels, and ROS formation.
.10. Statistical analysis
Comparison between groups was performed using t-test, one-
ay and two-way ANOVA analysis followed by Tukey’s post hoc
est in the SPSS package software (version 21) and Graph-pad
rism software (version 6). P < 0.05 was considered statistically
igniﬁcant. The factors were housing (social condition (SC) and
solation condition (IC)) and treatments (control: no treatment
nd treatment: drug-administered animals by i.p. injection) for all
ssessments.
. Results
.1. Effects of housing conditions on depressive and locomotion
ehaviors
Applying SIS to mice in adolescence provoked depressive-like
ehaviors in IC mice when compared to SC animals. Fig. 1 shows
hat the immobility time increased in the IC compared to SC ani-
als as measured by FST (t = 5.1, df = 14, P < 0.001, Fig. 1a). Lack
f motivation and self-care difﬁculties in mice, as symptoms of
epression, is determined by a reduction in grooming activity time
n the splash test. Results show that SIS caused a signiﬁcant reduc-
ion in grooming time in the splash test when compared to the
C animals (t = 6.964, df = 14, P < 0.001, Fig. 1b). OFT data indicates,
IS signiﬁcantly increased the total distance moved (horizontal
ctivity) (t = 3.442, df = 14, P < 0.01, Fig. 1c) and number of rear-
ngs (vertical activity) (t = 4.213, df = 14, P < 0.001, Fig. 1d) in IC mice
hen compared to SC mice.
.2. Effects of tropisetron on locomotion and depressive -like
ehaviors
We  assessed the effects of various doses of tropisetron (1,
 and 5 mg/kg) on depressive-like and locomotion behaviors in
oth SC and IC mice using the aforementioned tasks. ANOVA
nalysis revealed that there were signiﬁcant differences between
ropisetron-treated groups in immobility time as measured by FST
F (9, 70) = 6.123, P < 0.001, Fig. 2a), grooming activity time assessed
y splash test (F (9, 70) = 12.50, P < 0.001, Fig. 2b), distance moved
n OFT (F (9, 70) = 6.521, P < 0.001, Fig. 2c), and number of rearings
n OFT (F (9, 70) = 11.20, P < 0.001, Fig. 2d).h Bulletin 124 (2016) 150–163
In the FST, tukey’s analysis showed that administration of
tropisetron (3 and 5 mg/kg, but not 1 mg/kg) to IC mice signiﬁcantly
decreased the immobility time in comparison with saline-treated IC
mice (P < 0.05 and P < 0.01, respectively). Treatment with all doses
of tropisetron produced no signiﬁcant alterations in the immobil-
ity time of SC mice when compared with saline-treated SC mice as
measured by FST (P > 0.05).
In the splash test, tukey’s analysis shows that administration of
tropisetron (3 and 5 mg/kg, but not 1 mg/kg) enhanced the groom-
ing activity of IC animals when compared to IC-saline treated group
(P < 0.05 and P < 0.001, respectively). However, the results showed
that administration of same doses of tropisetron had no signiﬁcant
effect on grooming activity time of SC groups (P > 0.05).
In the OFT, administration of tropisetron (1, 3, 5 mg/kg) did not
affect total distance moved and number of rearings of SC and IC
mice in comparison with saline-treated SC and IC groups (P > 0.05).
Further, our results showed that saline treatment did not affect the
behaviors of both SC and IC mice in all applied behavioral tests
(P > 0.05).
3.3. Effects of NOS inhibitors and NO precursor on locomotion
and depressive-like behaviors
In order to assess the effect of NOS inhibitors and NO precur-
sor on depressive-like behaviors in animals, we  investigated the
effects of different doses of L-NAME, AG, and l-arg on animal behav-
iors using the aforementioned tasks. Using ANOVA analysis, we
showed that there are signiﬁcant differences between L-NAME-
treated groups as well as aminoguanidine-administered groups
in immobility time in the FST (F (5, 42) = 4.624, P < 0.01; F (5,
42) = 6.778, P < 0.001, Fig. 3a), grooming activity time in the splash
test (F (5, 42) = 16.99, P < 0.001; F (5, 42) = 13.07, P < 0.001, Fig. 3b),
distance moved in OFT (F (5, 42) = 6.503, P < 0.001; F (5, 42) = 7.954,
P < 0.001, Fig. 3c), and number of rearings in OFT (F (5, 42) = 17.47,
P < 0.001; F (5, 42) = 13.67, P < 0.001, Fig. 3d). Also, there are signiﬁ-
cant differences between l-arginine-treated animals in immobility
time (F (5, 42) = 7.154, P < 0.001, Fig. 3a), grooming activity time (F
(5, 42) = 25.53, P < 0.001, Fig. 3b), distance moved (F (5, 42) = 7.628,
P < 0.001, Fig. 3c), and number of rearings (F (5, 42) = 15.24, P < 0.001,
Fig. 3d).
Tukey’s analysis showed that administration of L-NAME (5
and 10 mg/kg) had no effect on the behavioral tests of SC ani-
mals (P > 0.05). But, in comparison with saline-treated IC mice,
administration of L-NAME (10 mg/kg) signiﬁcantly decreased the
immobility time of IC mice in FST (P < 0.05) and increased groom-
ing activity time in splash test (P < 0.01). However, administration
of the lower dose of L-NAME (5 mg/kg) did not alter the immobility
and grooming time of IC mice in comparison with saline-treated IC
group (P > 0.05). Further, our results show that L-NAME treatment
did not affect the locomotor activity of IC mice in the OFT (P > 0.05).
Additional analysis revealed that administration of AG (20
and 50 mg/kg) had no behavioral effect on SC animals when
assessed by behavioral tasks (P > 0.05). However, in comparison
with saline-treated IC mice, results showed that administration of
AG (50 mg/kg, but not 20 mg/kg) signiﬁcantly decreased the immo-
bility time of IC mice in the FST (P < 0.01). Also, treatment with AG
(50 mg/kg, but not 20 mg/kg) improved the grooming activity time
of IC mice when compared to saline-treated IC group (P < 0.001). In
the OFT, AG (20 and 50 mg/kg) did not affect both horizontal and
vertical activity of IC animals (P > 0.05).
Furthermore, treatment with l-arg (50 and 100 mg/kg) had no
effect on all behavioral tests including FST, splash test, and OFT in
both SC and IC animals (P > 0.05).
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.4. Effects of nitrergic system on antidepressant-like properties
f tropisetron
.4.1. Depressive-like behaviors in the FST
In SC groups, statistical analysis revealed that co-administration
f sub-effective doses of NOS inhibitors/NO precursor with sub-
ffective dose of tropisetron had no effect on the immobility time
n the FST (P > 0.05, Fig. 4a, c and e). However, the results were
ifferent in IC groups.
Co-administration of L-NAME (5 mg/kg) along with tropisetron
1 mg/kg) decreased the duration of immobility in IC animals when
ompared to saline-treated IC controls (P < 0.05, Fig. 4b). Two-way
NOVA analysis revealed signiﬁcant differences in the FST for the
ropisetron treatment (F (1, 28) = 4.73, P < 0.05).
Also, injecting a sub-effective dose of AG (20 mg/kg) to
ropisetron-treated IC animals (1 mg/kg) caused obvious
ntidepressant-like effect revealed in the FST (decrease in immo-
ility time) when compared to saline-treated IC mice (P < 0.01,
ig. 4d). Two-way ANOVA analysis revealed signiﬁcant differences
or the tropisetron treatment (F (1, 28) = 8.8, P < 0.01).
In addition, treatment with sub-effective dose of l-arg
100 mg/kg) abolished the antidepressant-like effect of tropisetron
5 mg/kg, effective dose) by increasing the immobility time
P < 0.01, Fig. 4f). Two-way ANOVA analysis revealed signiﬁcant dif-
erences for the tropisetron treatment (F (1, 28) = 8.485, P < 0.01),
-arg treatment (F (1, 28) = 4.456, P < 0.05), and tropisetron× l-arg
nteraction (F (1, 28) = 6.064, P < 0.05).
.4.2. Depressive-like behaviors in the splash test
In comparison to saline-treated IC mice, treating IC mice
ith tropisetron (1 mg/kg) and L-NAME (5 mg/kg) signiﬁcantly
ncreased the grooming activity time in the splash test (P < 0.05,
ig. 5b). Two-way ANOVA analysis demonstrated signiﬁcant differ-
nces in the grooming activity time for the tropisetron treatment
lone (F (1, 28) = 6.233, P < 0.05).
In addition, co-administration of tropisetron (1 mg/kg) with AG
20 mg/kg) to IC mice induced a signiﬁcant increase in the groom-
ng activity time in the splash test (P < 0.001, Fig. 5d) as compared
o saline-treated IC mice. Two-way ANOVA analysis showed sig-
iﬁcant differences in the splash test for the tropisetron treatment
lone (F (1, 28) = 8.615, P < 0.01) and AG treatment (F (1, 28) = 9.126,
 < 0.01).
Further, comparison with saline-treated IC controls showed that
dministration of l-arg (100 mg/kg) abolished the antidepressant
ffect of tropisetron (5 mg/kg) by reducing the grooming activity
ime in the splash test (P < 0.05, Fig. 5f). Two-way ANOVA analysis
evealed signiﬁcant differences in the splash test for the tropisetron
reatment alone (F (1, 28) = 10.09, P < 0.01), l-arg treatment (F (1,
8) = 3.9, P < 0.05), and tropisetron × l-arg treatment interaction (F
1, 28) = 5.322, P < 0.05). In comparison to saline-treated SC mice,
dministration of the same doses of above drug combinations had
o effect on the depressive-like behaviors of SC mice in the splash
est (P > 0.05, Fig. 5a, c and e).
.4.3. Horizontal and vertical activities in the OFT
Co-administration of L-NAME (5 mg/kg) or AG (20 mg/kg) with
ropisetron (1 mg/kg) did not change either distance moved
P > 0.05, Fig. 6a–d) or number of rearings (P > 0.05, Fig. 7a–d) in
he SC and IC animals in comparison with saline-treated controls.
wo-way ANOVA analysis revealed no signiﬁcant differences in the
otal distance moved and number of rearings in the OFT in the SC
nd IC animals (P > 0.05).Furthermore, co-administration of the effective dose of the
ropisetron (5 mg/kg) with sub-effective dose of l-arg (100 mg/kg)
id not alter the locomotion behaviors of SC and IC mice (P > 0.05,
igs. 6e and f and 7e and f) and similarly, through two-way Bulletin 124 (2016) 150–163 159
ANOVA analysis we  determined there are no signiﬁcant dif-
ferences between tropisetron treatment, l-arg treatment, and
tropisetron × l-arg for total distance moved and number of rearings
in the SC and IC animals (P > 0.05).
3.5. Effects of different housing conditions and drug treatments
on mitochondrial function and O&NS
3.5.1. Effects of housing conditions and drug treatments on GSH
levels in the cortex
Two-way ANOVA analysis revealed that there were signiﬁ-
cant effects as a result of housing conditions (F (1, 72) = 109.8,
P < 0.001) as well as housing conditions × treatments interaction
(F (11, 72) = 5.404, P < 0.001) on cortical GSH  levels in animals
(Table 1). Multiple analyses show a signiﬁcant decrease in the GSH
levels of cortical cytosolic fraction of IC mice in comparison with
SC animals (P < 0.001).
The administration of tropisetron (5 mg/kg) signiﬁcantly
restored GSH levels in comparison with saline-treated IC mice
in the cortex (P < 0.001). However, treatment with tropisetron
1 mg/kg failed to induce any signiﬁcant change in GSH levels when
compared to saline-treated IC mice (P > 0.05).
Similarly, administration of sub-effective doses of L-NAME
(5 mg/kg), AG (20 mg/kg), and l-arg (50 an 100 mg/kg) had no sig-
niﬁcant change on the cortical GSH levels in IC mice as compared
to controls (P > 0.05). However, higher doses of L-NAME (10 mg/kg)
(P < 0.05) and AG (50 mg/kg) (P < 0.001) signiﬁcantly affected the
cortical GSH levels in IC animals. In comparison with saline-treated
IC mice, treating IC mice with AG 20 mg/kg in combination with
tropisetron (1 mg/kg) signiﬁcantly restored GSH levels in the cor-
tex (P < 0.001). Also, co-administration of L-NAME (5 mg/kg) in
combination with tropisetron (1 mg/kg) signiﬁcantly restored GSH
levels in the cortex (P < 0.01). In addition, administration of l-arg
(100 mg/kg) signiﬁcantly lowered the elevated levels of GSH in the
IC mice treated with tropisetron (5 mg/kg) in the cortex (P < 0.001).
This data shows that administration of all applied drugs did not
change the cortical GSH levels in SC animals when compared to SC
control group (P > 0.05).
3.5.2. Effects of housing conditions and drug treatments on ATP
levels in the cortex
Results obtained from two-way ANOVA analysis show that
there were signiﬁcant effects due to housing conditions (F (1,
74) = 459.4, P < 0.001), treatments (F (11, 74) = 15.79, P < 0.001), and
their interactions (F (11, 74) = 27.42, P < 0.001) on the cortical ATP
levels (Table 1). Multiple analyses revealed that there is a sig-
niﬁcant decrease in ATP production in the cortex (P < 0.001) of
IC mice as compared with SC controls (Table 1). Treatment of IC
mice with tropisetron (5 mg/kg) increased ATP levels in the cortex
(P < 0.001) in comparison with IC control mice. Furthermore, co-
administration of sub-effective dose of l-arg (100 mg/kg) abolished
the positive effect of tropisetron on ATP generation (P < 0.001). Con-
versely, co-administration of L-NAME (5 mg/kg) or AG (20 mg/kg)
with tropisetron (1 mg/kg) signiﬁcantly increased ATP levels in the
cortex (P < 0.001 and P < 0.001 respectively) of IC mice in compari-
son with controls. Our data shows that administration of all applied
drugs had no any signiﬁcant effect on the cortical ATP levels in SC
animals when compared to SC control group (P > 0.05).
3.5.3. Effects of housing conditions and drug treatments on nitrite
levels in the cortex
Two-way ANOVA analysis revealed that there were signiﬁcant
effects as a result of housing conditions (F (1, 87) = 1451, P < 0.001),
treatments (F (11, 87) = 15.32, P < 0.001), and their interactions (F
(11, 87) = 7.849, P < 0.001) on the cortical nitrite levels (Table 1). The
data indicates that IC mice have greater levels of cortical nitrite con-
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Table 1
Effect of different housing conditions (SC and IC) and treatments on GSH, ATP, and nitrite levels in the cortex. Values are expressed as Mean ± S.D. of 3–6 samples and were
analyses using two-way ANOVA followed by Tukey’s post hoc test. * P < 0.05, ** P < 0.01, and *** P < 0.001 compared with SC control group. #P < 0.05, ## P < 0.01, and ###
P  < 0001 compared with IC control group in each column.
Treatments/Conditions GSH (g/mg protein) ATP (nmol/mg protein) Nitrite (nmol/mg protein)
SC IC SC IC SC IC
+Saline 36.4 ± 5.9 16.58 ± 3.7*** 3.37 ± 0.2 1.06 ± 0.17*** 30.5 ± 4 53 ± 5***
+Tropisetron (1 mg/kg) 35.3 ± 3.3 23.5 ± 5.4** 3.1 ± 0.25 1.55 ± 0.3#*** 29.1 ± 6 47 ± 6***
+Tropisetron (5 mg/kg) 31.9 ± 7.1 30.1 ± 4.8### 3.1 ± 0.2 3.1 ± 0.2### 28.4 ± 5.7 34 ± 4###
+LNM (5 mg/kg) 34.9 ± 2.8 22.8 ± 3.7* 3 ± 0.3 1.15 ± 0.3*** 28.2 ± 7.6 50 ± 7***
+LNM  (10 mg/kg) 30.5 ± 4.8 26.2 ± 2.9# 3.3 ± 0.4 2.16 ± 0.2###** 27.12 ± 8.7 38 ± 5##
+AG  (20 mg/kg) 35.5 ± 8.1 22.9 ± 2.1** 2.9 ± 0.3 1.55 ± 0.3#*** 27.7 ± 8 45 ± 6***
+AG  (50 mg/kg) 34.7 ± 6.7 29.9 ± 4.2### 3.1 ± 0.3 2.96 ± 0.2### 25.9 ± 8.3 32 ± 5###
+l-arg (50 mg/kg) 37.1 ± 3.1 16.41 ± 3.1*** 3.3 ± 0.4 1.04 ± 0.2*** 30.1 ± 6 54 ± 6***
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m+  l-arg (100 mg/kg) 39.2 ± 7.3 16.1 ± 2.7*** 
+Tropisetron (1 mg/kg) + LNM (5 mg/kg 29.8 ± 7.1 28.3 ± 3.8## 
+Tropisetron (1 mg/kg) + AG (20 mg/kg) 33.1 ± 6.2 33.5 ± 4.5###
ent in comparison with SC animals (P < 0.001) (Table 1). Also, there
as no signiﬁcant difference in the cortical nitrite levels between
C control mice and IC mice treated with sub-effective doses of
G (20 mg/kg), L-NAME (5 mg/kg), l-arg (50 and 100 mg/kg), and
ropisetron (1 mg/kg) (P > 0.05). In comparison with IC control mice,
 signiﬁcant decrease in cortical nitrite levels was observed when IC
ice were treated with tropisetron (5 mg/kg) (P < 0.001). Also, co-
dministration of sub-effective doses of l-arg (100 mg/kg) blocked
he effect of tropisetron (5 mg/kg) on elevated cortical nitrite levels
P < 0.001). Furthermore, co-administration of L-NAME (5 mg/kg) or
G (20 mg/kg) with tropisetron (1 mg/kg) signiﬁcantly decreased
itrite levels in the cortex of IC mice in comparison with controls
P < 0.01 and P < 0.001 respectively). Conversely, our data shows
hat administration of all applied drugs did not change the cor-
ical nitrite levels in SC animals in comparison to SC control group
P > 0.05).
.5.4. Effects of housing conditions and drug treatments on ROS
ormation in the cortex
Assessment of ROS formation was performed at 2 time inter-
als (5 min  and 45 min) in the cortex (Fig. 8) of animals. The signs
or increased ROS formation in ﬂow cytograms are shifting of the
OS peak to the right and not just increased the area under the
urve (AUC). As shown in Fig. 8, there is a signiﬁcant concentra-
ion dependent shift of 2′,7′-dichloroﬂuorescein diacetate (DCF)
eak to the right in the cortex of IC group when compared with
C group (Fig. 8A and B). Therefore, an increase in ROS genera-
ion in the cortex of IC mice was observed at both 5 and 45 min
ntervals. Treating IC mice with AG (20 mg/kg), L-NAME (5 mg/kg),
-arg (50 and 100 mg/kg), and tropisetron (1 mg/kg) did not obvi-
usly affect the elevated levels of ROS formation in the cortex.
lso, in comparison with IC controls, administration of tropisetron
5 mg/kg) to IC animals reversed the cortical (Fig. 8D) ROS forma-
ion to the normal state, albeit, the latter effect was  abolished by
dministration of l-arg (100 mg/kg) (Fig. 8H). As shown in Fig. 8I
nd J, co-administration of L-NAME (5 mg/kg) or AG (20 mg/kg)
ith tropisetron (1 mg/kg) decreased the enhanced ROS produc-
ion in the cortex of IC animals at both 5 min  and 45 min  intervals
Fig. 8I and J).
. Discussion
.1. Depressive-like behaviors following early SIS correlated with
itochondrial dysfunction and oxidative challenge in the cortexResults of the current study revealed that experiencing SIS dur-
ng adolescence provoked depressive-like behaviors in adult male
ice. These behavioral alterations correlated with elevated levels3.45 ± 0.3 1.01 ± 0.27*** 33.3 ± 7 57 ± 8***
3 ± 0.35 3.03 ± 0.25### 27.8 ± 5.7 39 ± 6##*
3.15 ± 0.3 3.22 ± 0.4### 28.1 ± 9 31 ± 4###
of O&NS and mitochondrial dysfunction in the cortex of the ani-
mals. In addition, our results showed that administration of both
NOS inhibitors and tropisetron (alone or in combination) mitigated
the negative effects of early SIS on the behavioral proﬁle of mice.
Also, the same treatments improved the mitochondrial function
and oxidative state in the cortex. Furthermore, the nitrergic sys-
tem seemed to be involved in the antidepressant-like effects of
tropisetron as the administration of l-arg (NO precursor) abolished
the protective effects of tropisetron.
Adolescence is a determinant state in the timing of brain
development during which, the cortico-limbic circuits undergo sig-
niﬁcant alterations (Andersen and Teicher, 2008; Lupien et al.,
2009). The developing brain is vulnerable to environmental chal-
lenges (such as stress overload) resulting from high energy
demands, number of immature cells and poor antioxidant sys-
tem defense (Hagberg et al., 2014; Ikonomidou and Kaindl, 2011).
Emerging lines of research suggest that mitochondrial dysfunction
plays a role in the etiology of MDD  owing to its role in a vari-
ety of vital cell functions including energy metabolism, response
to glucocorticoids and ROS production (Morava and Kozicz, 2013;
Picard et al., 2014). Recently, we have demonstrated that SIS during
adolescence is associated with severe mitochondrial dysfunction
in the brain (unpublished data). Considering the negative impacts
of early life stress on mitochondrial function and evolution, we
showed that 4-weeks of juvenile SIS induced overproduction of ROS
in the cortex of IC mice. Excessive generation of ROS is associated
with poor oxidative phosphorylation in the mitochondrial respi-
ratory chain, which negatively impacts on the generation of ATP
as the vital molecule required for cell survival (Picard et al., 2014).
Results of this study revealed that there was a signiﬁcant difference
in ATP levels in the cortex between the IC and SC rats indicating
the disruption of energy hemostasis in the cortical regions of the
brain in IC mice. In addition, we  showed that the overproduction
of ROS accompanied by a decrease in GSH levels, which is consid-
ered as the main antioxidant agent in the brain. Increasing of ROS
in mitochondria and neighboring of ROS production site to lipid
membrane, makes more susceptible site in mitochondria which
leads to oxidative stress and lipid peroxidation. Also, glutathione
is an important component of non-enzymatic antioxidant system
that not only modulates the deleterious effects of free radicals but
also markedly plays an important role in pathophysiology of psy-
chiatric disorders (Gawryluk et al., 2011a,b). Our  results showed
there was  a signiﬁcant reduction in the mitochondrial GSH lev-
els between the IC and SC controls in line with previous studies
reporting that mitochondrial dysfunction following chronic stress
is implicated in the pathogenesis of depression (Gong et al., 2011;
Leonard and Maes, 2012). We  also demonstrated that adolescence
SIS potently increased nitrite levels in the cortex reﬂecting the pres-
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nce of nitrosative stress in these regions. Overproduction of NO in
hese regions has been reported to inhibit the ATP synthesis by
itochondria as well as considerably reducing GSH levels through
-nitrosylation (Almeida and Bolan˜os, 2001; Anand and Stamler,
012). Collectively, these alterations following 4-weeks of SIS in the
dolescent stage suggest that depressive-like behaviors in IC mice
s associated with signiﬁcant impairment in the mitochondrial and
edox system in the cortex.
Through the application of behavioral tests to investigate the
nﬂuence of early SIS on the depressive-like behaviors, we  showed
hat adolescent SIS provoked despair behavior (increased immobil-
ty time in the FST) as well as difﬁculties in motivation and self-care
ehaviors in mice (reduction in the grooming activity time in the
plash test) (Cryan et al., 2002; Petit et al., 2014). These behaviors
re considered as the main symptoms of depression observed in
umans indicating that early SIS induces depressive-like behaviors
n IC mice. It is important to note that FST is a cogent and rapid
creening test for the evaluation of novel antidepressants and is
ased on observations of depressed patients not being able to cope
ith stressful conditions and similarly, depressed rodents behave
he same in the stressful conditions (cylinder ﬁlled with water)
y exhibiting passive behaviors (Castagné et al., 2011; Cryan and
olmes, 2005). In this study, we also used the splash test as a suit-
ble tool to evaluate motivation and self-care behavior based on
rooming behavior (Ducottet et al., 2003; Marrocco et al., 2014).
urthermore, enhanced vertical and horizontal activity of IC mice
n the OFT not only validated the FST results but showed the anxi-
ty response of IC mice to a novel environment. These results were
onsistent with other studies, which demonstrate that early SIS is
ble to provoke behaviors relevant to depression in animals (Amiri
t al., 2015b; Berry et al., 2012; Grippo et al., 2007).
.2. Nitric oxide is involved in the protective effects of tropisetron
gainst behavioral and mitochondrial dysfunction
Recent studies on animal models of depression have demon-
trated the antidepressant-like properties of the 5-HT3 receptor
ntagonists, including tropisetron (Carr and Lucki, 2011; Rajkumar
nd Mahesh, 2010). Normal performance of cortical areas is tightly
ssociated with the structure of cortical circuits. 5-HT3 receptors
lay a pivotal role during development of cortico-limbic circuits
y regulating the neuronal migration and differentiation during
arly stages of life. Recent evidence indicates that experiencing
arly-life stress negatively affects 5-HT3 receptor function leading
o an increased risk of developmental psychiatric disorders (Vitalis
t al., 2013). The results of this study show that administration of
ropisetron or NOS inhibitors exerted antidepressant-like effects
n IC mice subjected to FST and splash test. Behavioral improve-
ents in IC mice were associated with signiﬁcant amelioration of
itochondrial function as well as redox state in the hippocam-
us (data not shown) and cortex. It has been generally accepted
hat under chronic stress conditions that an overproduction of
O (through iNOS) is involved in pathophysiology of depression
Chen et al., 2015; Montezuma et al., 2012). In this regard, evi-
ence indicates that high levels of NO (ir) reversibly suppresses
itochondrial respiration and ATP synthesis and induce cellular
amage mainly in the cortical areas (Moncada and Erusalimsky,
002; Sarti et al., 2012). Interestingly, it has been reported that
NOS is implicated in the pathogenesis of depression and inhibition
f this enzyme is associated with improvements in mitochon-
rial function and depressive-like behaviors (Gałecki et al., 2010;
ontezuma et al., 2012; Sarti et al., 2012). Our results are in agree-
ent with studies, which have revealed that cortical iNOS plays
 role in mediating depressive-like behaviors as determined by
nhibiting iNOS using AG or 1400W induced antidepressant-like
ffects in animal models of chronic stress including early SIS (Amiri Bulletin 124 (2016) 150–163 161
et al., 2015b; Montezuma et al., 2012; Peng et al., 2012). On the
other hand, tropisetron showed antidepressant-like effects while
administered to IC mice. Co-administration of AG or L-NAME with
tropisetron at sub-effective doses reversed the deleterious impacts
of early SIS as determined through neurochemical and behavioral
analysis suggesting the mediatory role of the nitrergic system in
protective effects of tropisetron on mitochondrial function and
oxidative state. To support this, pretreatment with l-arg potently
abolished the effects of tropisetron indicating that antidepressant-
like effects of tropisetron are partly mediated by mitigating the
adverse effects of iNOS activity on the mitochondrial function as
well as anti-oxidant system in the cortical regions. It is impor-
tant to note that although the antidepressant-like effects of NOS
inhibitors have been well documented in the literature, only AG
(but not 7-NI as a neuronal NOS inhibitor) exhibited protective
properties in IC mice (data not shown). To explain the positive
effects of tropisetron on behavioral and biochemical conditions
of IC mice, it is important to state that the cerebral cortex con-
tains abundant 5-HT3 positive neurons which control the excitatory
and inhibitory processes relevant to higher-order cognitive func-
tions. Nearly 30% of cortical interneurons are 5-HT3 positive and are
located in the superﬁcial layers of the neocortex (Engel et al., 2013;
Rudy et al., 2011). 5-HT3 receptors are implicated in the pathophys-
iology of depression as their activation by glucocorticoids results
in calcium inﬂux and consequently the release of glutamate from
presynaptic synaptosomes in prelimbic cotical areas (Rajkumar
and Mahesh, 2010; Zhang et al., 2012). Except for the inhibitory
properties of GABAergic interneurons in the cortex, 5-HT3 positive
interneurons have been reported to exhibit dis-inhibitory role that
cause activity of pyramidal glutamatergic neurons in the cortex (Pi
et al., 2013). Thus, antidepressant-like activity of tropisetron may
be associated with its ability to decrease calcium inﬂux into cells
and alleviation of mitochondrial dysfunction. Furthermore, results
from our laboratory and others indicate that the protective prop-
erties of tropisetron under pathological conditions are associated
with its anti-inﬂammatory properties (Rahimian et al., 2011, 2013;
Swartz et al., 2013). Recent investigations in our laboratory demon-
strated that tropisetron reduced the expression of iNOS, release of
mitochondrial cytochrome c and TNF- levels in the hippocampus
following the administration of beta-amyloid (A)  (Rahimian et al.,
2013). Similar results were observed while tropisetron efﬁciently
diminished the oxidative stress and iNOS expression in the kid-
ney following cisplatin toxicity (Zirak et al., 2014). Accordingly, we
suggest that the antidepressant-like effects of tropisetron may  be
related to its modulatory effects on the NO (by iNOS) and ROS  over-
production which together produce large amounts of peroxynitrite
in the speciﬁc regions of the brain and initiate the inﬂammatory
responses. Our study is not without limitation where we  showed
that the nitrergic system is involved in the tropisetron effects, we
did not speciﬁcally determine whether the protective effects of
tropisetron were related to the antagonization of 5-HT3 receptors
or partial activation of 7 nicotinic acetylcholine receptors. Consid-
ering that 5-HT3 receptors consisted of divergent homomeric and
heteromeric subtypes that are expressed in various patterns in dif-
ferent tissues (Faerber et al., 2007), uncertain responses evoked by
tropisetron are expected through 5-HT3 (in) dependent pathways.
5. Conclusion
In conclusion, our previous reports on the protective effects of
tropisetron have indicated that in various pathological conditions
such as Alzheimer’s disease, anxiety-like behaviors and ischemia
tropisetron may  exert its effects through a variety of mechanisms
such anti-inﬂammatory effects. In this study, we  found that the
antidepressant-like effects of tropisetron (5 mg/kg) in socially iso-
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